Carmell Therapeutics Corp... (CTCX)
NASDAQ: CTCX
· Real-Time Price · USD
0.20
0.01 (2.77%)
At close: Mar 07, 2025, 3:55 PM
Carmell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -7.69M | -23.2M | -19.57M | -15.45M | -21.72M | -7.28M | -7.95M | -9.05M | -6.17M | -1.2M | -849.34K | -321.81K | -87.3K |
Depreciation & Amortization | -504.3K | 190.26K | 194.07K | 196.41K | 605.38K | 181.58K | 119.5K | 59.59K | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 998.42K | 675.31K | 698.64K | 667.68K | 765.37K | 527.61K | 340.58K | 160.07K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -5.99M | -2.46M | -919.25K | -1.42M | 5.76M | 3.35M | 2.05M | 1.5M | 1.31M | 641.16K | 398.52K | 15.05K | -283.92K |
Other Non-Cash Items | 10.56M | 17.76M | 13.76M | 10.71M | 9.79M | -1.21M | 454.6K | 2.12M | 2.93M | -350.96K | -145.66K | -138.05K | -2.65K |
Deferred Income Tax | -324.31K | -324.31K | -324.31K | -324.31K | 942.09K | 942.09K | 942.09K | 942.09K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.49M | -4.79M | -3.06M | -3.42M | 2.84M | 3.92M | 2.88M | 2.34M | 2.04M | 907.57K | 398.52K | 15.05K | -283.92K |
Operating Cash Flow | -2.91M | -10.39M | -9.25M | -8.35M | -7.5M | -3.41M | -3.45M | -3.43M | -1.2M | -639.71K | -596.48K | -444.8K | -373.88K |
Capital Expenditures | -4 | -30.47K | -30.47K | -30.47K | -34.05K | -3.58K | -3.58K | -3.58K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -748.8K | -85.8K | -85.8K | 663K | 663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -154.44M | -154.44M | -154.44M | -154.44M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -748.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.16M | -779.27K | -809.74K | -60.94K | 598.47K | -34.05K | -3.58K | -3.58K | n/a | -154.44M | -154.44M | -154.44M | -154.44M |
Debt Repayment | -541.88K | -3.98M | -3.29M | -2.69M | -2.25M | 848.5K | 375K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.13M | 17.35M | 14.72M | 14.69M | 17.07M | 2.77M | 2.71M | 2.69M | 1.1M | -116.33K | -88.55K | -60.76K | -56.23K |
Financial Cash Flow | 3.59M | 13.41M | 10.59M | 11.16M | 14.83M | 3.58M | 3.93M | 3.52M | 1.1M | 155.6M | 155.63M | 155.66M | 155.66M |
Net Cash Flow | -3.79M | -2.87M | -4.18M | 2.72M | 7.9M | -600.77K | -638.12K | -646.04K | -838.77K | 551.5K | 594.73K | 774.19K | 849.65K |
Free Cash Flow | -2.91M | -10.42M | -9.28M | -8.38M | -7.54M | -3.41M | -3.45M | -3.43M | -1.2M | -639.71K | -596.48K | -444.8K | -373.88K |